VAX-ID®新型皮内注射装置的性能、安全性与可用性临床前评估
本文综述VAX-ID®皮内给药装置的临床前数据,评估其死腔体积、剂量准确性、仔猪皮肤穿透深度与液体沉积,以及医护人员可用性。装置死腔体积低、剂量准确性高,能在真皮预定深度成功注射且安全性高,被医护人员评为易用。
要点
- VAX-ID®装置死腔体积低、剂量准确性高。
- 在仔猪中于真皮预定深度成功注射,视觉与组织学评估显示安全性高。
- 医护人员将该装置评为易用。
核心结论
- VAX-ID®可在皮肤真皮层提供可靠、标准化且准确的给药,且易用性高,为多种预防性和治疗性疫苗注射提供解决方案。
研究设计与样本
- 本文提供VAX-ID®皮内给药装置的临床前数据概述,评估其性能、安全性和可用性。
主要发现
- VAX-ID®装置死腔体积低、剂量准确性高。
- 装置在仔猪中于真皮预定深度成功注射,视觉和组织学评估证实安全性高。
- 医护人员将该装置评为易用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The recent SARS-Cov2 pandemic and mpox health emergency have led to renewed interest in intradermal vaccination due to its dose sparing potential. Indeed, intradermal vaccination is particularly of interest for use in mass vaccination campaigns, pandemic preparedness programs, and/or for vaccines that are expensive or in short supply. Moreover, the rich immune network in the skin makes it an attractive target not only for prophylactic vaccination, but also for therapeutic vaccination, like immunotherapy and (dendritic) cell-based therapies. The aim of the current paper was to provide an overview of preclinical data generated with VAX-ID®, a novel intradermal drug delivery device, to allow assessing it performance, safety and usability. The device can overcome challenges seen with the Mantoux technique whereby the needle needs to be inserted under a shallow angle. Various parameters of VAX-ID® were evaluated, including dead-space volume, dose accuracy, penetration depth & liquid deposit in piglets, as well as usability by healthcare professionals. The device has shown to have a low dead volume and a high dose accuracy. Importantly, the device performed successful injections at a predefined depth into the dermis with a high safety profile as confirmed by visual and histological evaluation in piglets. Moreover, the device was rated as easy to use by healthcare professionals. The combined preclinical performance and usability findings indicate that VAX-ID® can provide reliable, standardized and accurate drug delivery in the dermal layer of the skin with a high ease of use. The device offers a solution for injection of various prophylactic as well as therapeutic vaccines.
引用
- Beyers KCL, Rbeihat MNM, S Vasconcelos D, et al. Preclinical evaluation of performance, safety and usability of VAX-ID®, a novel intradermal injection device. Vaccine. 2023. PMID: 37330370. doi:10.1016/j.vaccine.2023.06.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。